|
|
|
When George Shinn was told by New Orleans doctors last week that he had prostate cancer, he reacted the way many patients do. "I was scared to death," he says. He also was skeptical, a not uncommon response. Cancer happens to...
It's been derided as a soup strainer, cookie duster, lip spinach and even face fungus, but if Australian expat Adam Garone has his way, each November the maligned mustache will become as potent a symbol in the fight against...
Accessing Information from the Web about Increasingly Common Disease Sites on the internet provide a plethora of information about medical matters. In addition to the men's health section of Suite 101 (which we, obviously,...
Registration is now open for the Society of Interventional Radiology's "Image-guided Interventional Oncology (IO) Therapies" Webinar, which will provide the latest updates on percutaneous and transcatheter treatment of liver...
Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in...
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the...
Dangerously low vitamin D levels may increase the risk of heart disease, colon cancer, and prostate cancer. They're suggesting we've grown dangerously leery of the sun and, specifically, that we need more of the ultraviolet...
Background:Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for human cancer therapy, prostate cancer still remains resistant to TRAIL. Both X-linked inhibitor of apoptosis (XIAP)...
Unum (NYSE: UNM) has enhanced the wellness benefit of its critical illness products by adding the H1N1 vaccine to the list of qualifying procedures. This year, the H1N1 flu virus is adding extra stress in the workplace,” said...
November 5, 2009 10:05 AM | No Comments Former Chicago Police Cmdr. Jon Burge's trial will be delayed until May 10 to allow him to be treated for prostate cancer, a federal judge ruled today. U.S. District Court Judge Joan...
